Recent News

• 09.09.2025 - H.C. Wainwright 26th Annual Global Investor Conference
• 09.09.2025 - H.C. Wainwright 26th Annual Global Investor Conference
• 09.04.2025 - Cantor Healthcare Conference
• 09.04.2025 - Cantor Healthcare Conference
• 09.04.2025 - Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
• 09.04.2025 - Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
• 09.04.2025 - Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
• 09.03.2025 - Francois Brisebois
• 09.03.2025 - Francois Brisebois
• 08.26.2025 - Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

Recent Filings

• 09.04.2025 - 144 Report of proposed sale of securities
• 09.04.2025 - 8-K Current report
• 09.04.2025 - EX-99.1 EX-99.1
• 08.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.15.2025 - EX-99.1 EX-99.1
• 08.15.2025 - 8-K Current report